表达IL-37的T细胞及其受体在炎症性肠病中的特征
Indiana Zorkau1, Peter J Eggenhuizen1, Marie Lee1
1Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia.
这项研究揭示了因特鲁金-37 (IL-37) 和其受体在炎症性肠病 (IBD) 患者的T细胞中具有差异性表达. 提高IL-37通路显示出恢复IBD免疫平衡的希望.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 分子生物学分子生物学
背景情况:
- 炎症性肠病 (IBD) 的发病过程涉及到促炎效应T细胞和调控T细胞 (Tregs) 之间的不平衡.
- 干白素-37 (IL-37) 是一种强大的抗炎细胞因子,但其在IBD中的T细胞中的作用尚未完全理解.
- 准IL-37信号传递是IBD的潜在治疗策略.
研究的目的:
- 研究IBD患者T细胞子集中的IL-37及其受体的表达.
- 确定IBD中T细胞功能障碍的分子驱动因素.
- 探索IL-37在调节Treg功能的治疗潜力.
主要方法:
- 来自健康对照组 (HC),克罗恩病 (CD) 和性结肠炎 (UC) 患者的T细胞子集 (PBMC和LPMC) 的流细胞计分析.
- CD3+IL-1R8+T细胞的RNA测序,以识别特定疾病的转录特征.
- 在IL-37治疗后Treg表型和抑制能力的体外评估.
主要成果:
- 与HC相比,IBD患者的T细胞子集中观察到IL-37及其受体的差异表达.
- 在IBDT细胞中发现了独特的转录特征,包括基质子和线粒体通路.
- 治疗IL-37维持了Treg FOXP3的表达和抑制性,与拉巴胺素相当.
结论:
- 表达IL-37和其受体的T细胞在IBD中表现出改变的特征,表明T细胞功能障碍.
- IL-37信号通路代表了一种新的治疗点,用于IBD的免疫平衡恢复.
- 调节IL-37可能为管理IBD相关炎症提供了一个新的策略.
更多相关视频
09:04DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
07:45Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases
Published on: September 1, 2017
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Characteristics of Life
